Shares on issue are 115m AT 82c = $92m
Westpac securities has it at $92m
Why is make cap showing up as $123m on HC
Debate the facts
Agile trial already cost over $7m Australian dollars and yet to commence
Many here are experts on Agile trials and believe that commercialisation can be achieved on minimal patient numbers in minimal timeframes and minimal costs
We were told countless times in past 12 months no more CR;s - yet there have been 2-3 and its only October 2020
Refer Concurrent trials 1-2 years ongoing and still no news or data
When TMZ has been around for decades and tried on tens of thousands varying patients etc
PFS or OS has been measured on n= 30 to date
Each to their own like I stated at $1 or 90c etc well overbought at this point in time
DYOR and not advice only opinion which is closer to reality than fantasy
Market Cap
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)